Belgium's Precirix Beats Biotech Blues With Major Cash Boost
Radiopharmaceuticals Specialist Raises €80m
Despite the sector's woes, strong companies that generate strong patient data based on solid science have a promising future, Precirix CEO Ruth Devenyns tells Scrip.
